Tensys Medical has received CE mark for its latest generation non-invasive hemodynamic patient monitoring systems called the TL-400 and TL-300. This approval allows immediate commercialization of the systems in Europe. The TL-400 offers ...
Tags: CE Mark
Tensys Medical has obtained State Food & Drug Administration (SFDA) approval for its new continuous, non-invasive hemodynamic patient monitoring system in the People’s Republic of China. The TL-300 T-Line system comprises of a ...
Tags: SFDA Approval, Tensys Medical
Zhejiang Shanshi Medical Device (Shanshi) has signed a commercial agreement with Tensys Medical, a developer of continuous, non-invasive hemodynamic patient monitoring systems. Under the agreement, Shanshi has gained rights to market ...
Tags: Shanshi, Tensys Medical, hemodynamic patient monitoring systems
Tensys Medical's new continuous, non-invasive hemodynamic patient monitoring system has obtained 510(k) clearance from the US Food and Drug Administration (FDA). The TL-300 system, a member of T-Line family, is designed for use in ...
Tags: Hemodynamic Patient Monitor, FDA Approval, TL-300 system